From this contrasting result obtained in the two different CKD populations analyzed, we assumed that the role of FGF23 in increasing n-6 and decreasing n-3 was attenuated when MCP1 was kept low by the immunosuppressive therapy in KTx. Here, CCL2 is linked to chronic kidney disease.